Single-pill treatment proves as effective at suppressing virus as multi-pill therapy, while long-acting preventive injections ...

A single-pill treatment to suppress HIV proved as effective as existing therapies of up to 11 tablets daily, the latest advance in a scientific “golden age” for treating the virus even as rich ...

In patients with HIV‑1 infection and virologic suppression, switching to an investigational regimen of doravirine plus ...

Three experimental injectable antiretrovirals – a novel capsid inhibitor and two next-generation integrase inhibitors – could ...

Although HIV infection remains a global public health challenge, ART has transformed it from a fatal illness to a manageable lifetime condition for those who are successfully being treated.Initially, ...

Dr. Paula Cannon is pursuing one of medicine’s most difficult goals: a cure for HIV.

A growing number of states are rolling back financial help for HIV medications, according to a recent analysis.

A recent experimental treatment may offer a new method to prevent HIV infection: by combining two antiviral tactics into a single antibody. In laboratory studies, the new molecule forced the virus to ...

Modern HIV treatment is one of medicine's great success stories. With today's therapies, many people living with HIV can ...

South Africa is in discussions with Gilead Sciences (GILD) to reach an agreement that allows the production of the U.S. biotech’s new twice-yearly HIV therapy, lenacapavir, in the country, home to the ...

Nearly 20 states are moving to restrict assistance programs that help people afford HIV medications and treatment.

Independent clinical validation strengthens ABL’s leadership in the fast‑growing HIV drug‑resistance testing market ABL ...